Skip to content

EXOZ EXOZ Cash ratio

Cash ratio at other companies

Gevo logo
GevoGEVO
2.9×+1.7×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
2.4×-0.7×
NAG
Niagen Bioscience, Inc. Common StockNAGE
2.9×+0.2×
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
1.2×0.0×
Opko Health logo
Opko HealthOPK
0.2×-0.3×
Upexi logo
UpexiUPXI
0.0×

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-3.3%
Enterprise value$76.57M+3.5%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Calculated from EXOZ’s reported figures.

Based on the most recent quarter.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's cash ratio?
EXOZ (EXOZ) reported cash ratio of 0.9× in Q1 2026.
How has EXOZ's cash ratio changed year-over-year?
EXOZ's cash ratio decreased by 84.5% year-over-year, from 5.9× to 0.9×.
What is the long-term trend for EXOZ's cash ratio?
Over 2 years (2023 to 2025), EXOZ's cash ratio has grown at a 739.8% compound annual growth rate (CAGR), from 0× to 1.9×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.